The kidney gets caught in a macrophage trap.

Area of Science:

• Nephrology
• Immunology
• Pathophysiology

Background:

• Myoglobin, a protein released from damaged muscle tissue, is a known nephrotoxic agent.
• Acute kidney injury (AKI) is a critical clinical condition with significant morbidity and mortality.
• The precise mechanisms by which myoglobin induces AKI remain incompletely understood.

Purpose of the Study:

• To elucidate the role of platelets and macrophage extracellular traps (METs) in myoglobin-induced AKI.
• To investigate the molecular pathways linking myoglobin to kidney damage.
• To identify potential therapeutic strategies targeting platelet and MET activation in AKI.

Main Methods:

• In vivo models of rhabdomyolysis and AKI.
• Platelet aggregation assays.
• Immunofluorescence staining for MET components.
• Flow cytometry to assess immune cell activation.
• Biochemical analysis of kidney injury markers.

Main Results:

• Myoglobin release correlated with AKI development in experimental models.
• Platelet activation and aggregation were significantly increased in response to myoglobin.
• Macrophage extracellular traps (METs) were detected in renal tissues of AKI patients and in experimental models, co-localizing with myoglobin.
• Inhibition of platelet function or MET formation attenuated myoglobin-induced kidney damage.

Conclusions:

• Myoglobin induces AKI through a mechanism critically dependent on platelet activation and the formation of macrophage extracellular traps (METs).
• Targeting platelet aggregation and MET formation represents a promising therapeutic approach for preventing or treating myoglobin-related AKI.
• This study reveals novel insights into the pathophysiology of AKI, linking muscle injury to immune cell-mediated kidney damage.